A detailed history of Rock Springs Capital Management LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 307,500 shares of SRPT stock, worth $37.5 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
307,500
Previous 284,000 8.27%
Holding current value
$37.5 Million
Previous $44.9 Million 14.41%
% of portfolio
1.31%
Previous 1.39%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$124.33 - $156.75 $2.92 Million - $3.68 Million
23,500 Added 8.27%
307,500 $38.4 Million
Q2 2024

Aug 14, 2024

SELL
$113.33 - $163.85 $4.94 Million - $7.14 Million
-43,600 Reduced 13.31%
284,000 $44.9 Million
Q4 2023

Feb 14, 2024

SELL
$67.31 - $124.76 $4.33 Million - $8.03 Million
-64,400 Reduced 16.43%
327,600 $31.6 Million
Q3 2023

Nov 14, 2023

SELL
$102.5 - $123.59 $3.38 Million - $4.08 Million
-33,000 Reduced 7.76%
392,000 $47.5 Million
Q2 2023

Aug 14, 2023

SELL
$106.4 - $157.19 $1.86 Million - $2.75 Million
-17,500 Reduced 3.95%
425,000 $48.7 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $763,945 - $1.01 Million
6,500 Added 1.49%
442,500 $61 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $605,160 - $792,780
6,000 Added 1.4%
436,000 $56.5 Million
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $151,420 - $238,480
2,000 Added 0.47%
430,000 $47.5 Million
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $252,600 - $361,680
4,000 Added 0.94%
428,000 $33.4 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $5.72 Million - $7.36 Million
74,000 Added 21.14%
424,000 $38.2 Million
Q3 2021

Nov 15, 2021

BUY
$65.97 - $92.48 $1.4 Million - $1.97 Million
21,250 Added 6.46%
350,000 $32.4 Million
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $2.1 Million - $2.99 Million
-16,750 Reduced 4.85%
328,750 $56 Million
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $612,240 - $1.08 Million
8,000 Added 2.37%
345,500 $44.6 Million
Q3 2019

Nov 14, 2019

BUY
$72.81 - $156.91 $910,125 - $1.96 Million
12,500 Added 3.85%
337,500 $25.4 Million
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $1.07 Million - $1.44 Million
-9,500 Reduced 2.84%
325,000 $49.4 Million
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $800,025 - $1.14 Million
7,500 Added 2.29%
334,500 $39.9 Million
Q4 2018

Feb 14, 2019

BUY
$97.32 - $148.76 $1.61 Million - $2.45 Million
16,500 Added 5.31%
327,000 $35.7 Million
Q3 2018

Nov 14, 2018

BUY
$115.31 - $161.51 $1.5 Million - $2.1 Million
13,000 Added 4.37%
310,500 $50.1 Million
Q2 2018

Aug 14, 2018

BUY
$71.74 - $153.69 $2.83 Million - $6.07 Million
39,500 Added 15.31%
297,500 $39.3 Million
Q4 2017

Feb 14, 2018

SELL
$47.64 - $56.75 $57,168 - $68,100
-1,200 Reduced 0.46%
258,000 $14.4 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $9.26 Million - $12.2 Million
259,200
259,200 $11.8 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.